Los Angeles, CA - 
(NewMediaWire) - October 4, 2021 - The Schall Law Firm, a national shareholder rights litigation
firm, announces the filing of a class action lawsuit against Zymergen
Inc. (“Zymergen” or “the Company”) (NASDAQ: ZY) for
violations of the
federal securities laws.
Investors who
purchased the Company's shares pursuant and/or traceable to the Company’s
initial public offering conducted in April 2021 (the “IPO”), are encouraged to
contact the firm before October 4, 2021.
If you are a
shareholder who suffered a loss, click here to participate.
We also encourage you
to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite
2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of
charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The class, in this case,
has not yet been certified, and until certification occurs, you are not
represented by an attorney. If you choose to take no action, you can remain an
absent class member.
According to the
Complaint, the Company made false and misleading statements to the market. Zymergen’s
key customers suffered from technical problems during the qualification process
for Hyaline including product shrinkage. Although the qualification process was
critical to achieving customer acceptance for Hyaline, the Company had very
little visibility into the process. The Company overestimated market demand for
the new product. This led to likely product delays and, in turn, delays in
revenue generation. Based on these facts, the Company’s public statements
throughout the IPO period were false and materially misleading. When the market
learned the truth about Zymergen, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm
represents investors around the world and specializes in securities class
action lawsuits and shareholder rights litigation.
This press release may
be considered Attorney Advertising in some jurisdictions under the applicable
law and rules of ethics.
CONTACT:
The Schall
Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
SOURCE:
The Schall Law Firm
